"Aquaman and the Lost Kingdom" 
in theaters beginning December 20

HONG KONG, Dec. 4, 2023 /PRNewswire/ — Govee, an innovator in the smart lighting and smart home industries, is excited to announce its newest partnership with Warner Bros. Pictures in anticipation of their upcoming release  "Aquaman and the Lost Kingdom." Today, the brand released  new light scene modes in collaboration with the film to bring users Aquaman-themed lighting experiences ahead of the theater debut internationally beginning 20 December, 2023, and in North America on December 22.

"We are thrilled to announce our partnership with Warner Bros. Pictures for ‘Aquaman and the Lost Kingdom.’ As the official smart lighting partner of the movie, we want to bring the magic of Atlantis to fans through our cutting-edge lighting and color-matching technology for an immersive experience," says Eric WU, Govee CEO.

Specialized Color-Matching Features for TV Backlight Lineup

Govee has customized the color-matching feature for its TV backlight products – the TV Backlight T2 and the TV Backlight 3 Lite. Once "Aquaman and the Lost Kingdom" is available in the home, users can select the Aquaman lighting effects on Govee products to enhance their movie-watching experience with colors that match the on-screen content.

Customized Themed Lighting Effects: Enjoy Atlantis At Home

In addition to themed color-matching feature for this collaboration, Govee has designed three new light modes to fit the Aquaman theme, allowing users to immerse themselves in the world of Atlantis. The lighting modes include:

Atlantis: Transform your home into Aquaman’s underwater kingdom with curated shades of blue. Aquaman: Inspired by the Super Hero’s suit, this theme shines brightly in yellow and green. Black Manta: Harness the piercing laser eyes of Aquaman’s great foe with red and green lighting effects.

The Aquaman-themed light scene modes will be supported by a range of Govee products, including the TV Backlight 3 Lite, TV Backlight T2, Christmas String Lights, Curtain Lights, Permanent Outdoor Lights, and Permanent Outdoor Lights Pro. Additionally, the Govee Home App will introduce a new Aquaman-themed skin, providing users with a fresh and exciting interface to navigate through.

The customized Aquaman-themed color-matching feature, light scene modes and UI will be available on December 4th, and users can easily experience them by connecting to the Govee Home App. Fans can experience the color-matching feature when the film becomes available for home viewing in 2024.

About Govee

Since 2017, Govee has been committed to making life smarter. As a leading global smart home solution company, the company aims to provide personalized and fun life experiences through innovation in the smart home space. This includes a close focus on ambient lighting solutions and home appliances. Govee is continuously building upon its ecosystem of smart products and improving the consumer experience in all scenarios. To learn more about Govee, please visit govee.com.

About Aquaman and the Lost Kingdom

Having failed to defeat Aquaman the first time, Black Manta, still driven by the need to avenge his father’s death, will stop at nothing to take Aquaman down once and for all. This time Black Manta is more formidable than ever before, wielding the power of the mythic Black Trident, which unleashes an ancient and malevolent force. To defeat him, Aquaman will turn to his imprisoned brother Orm, the former King of Atlantis, to forge an unlikely alliance. Together, they must set aside their differences in order to protect their kingdom and save Aquaman’s family, and the world, from irreversible destruction. Directed by James Wan, the film stars Jason Momoa, Patrick Wilson, Amber Heard, Yahya Abdul-Mateen II and Nicole Kidman; Dolph Lundgren and Randall Park also return. The film is produced by Peter Safran, Wan and Rob Cowan. The executive producers are Galen Vaisman and Walter Hamada. The screenplay is by David Leslie Johnson-McGoldrick, from a story by James Wan & David Leslie Johnson-McGoldrick and Jason Momoa & Thomas Pa’a Sibbett, based on characters from DC, Aquaman created by Paul Norris and Mort Weisinger. Warner Bros. Pictures Presents An Atomic Monster / A Peter Safran Production, "Aquaman and the Lost Kingdom." The film will be distributed worldwide by Warner Bros. Pictures and is set to open in theaters internationally beginning 20 December 2023 and in North America on December 22, 2023.

About Warner Bros. Pictures Group

Warner Bros. Pictures Group is comprised of Warner Bros. Pictures, New Line Cinema and Warner Bros. Pictures Animation. Warner Bros. partners with the world’s most inspiring storytellers to create extraordinary entertainment on every screen for the global audience. Warner Bros. Pictures Group has been at the forefront of the motion picture industry since its inception and continues to be a leading creative force, producing the broadest slate of films for worldwide theatrical release.

Source : Govee Partners with Warner Bros. for "Aquaman and the Lost Kingdom" to Bring an Immersive Lighting Experience to Fans

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Agreement marks a significant expansion of Masdar’s European renewable energy portfolio Projects in Poland are expected to come online between 2026 and 2030 and will have a total combined capacity of more than 1GW Project on eight sites will operate a hybrid of solar photovoltaic (PV) and onshore wind to maximize grid allocation

DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ — COP28, Expo City Dubai Abu Dhabi Future Energy Company PJSC – Masdar, the UAE’s clean energy powerhouse, today announced the acquisition of eight hybrid renewable energy projects, along with Taaleri Energia, a Finnish-based renewable energy developer and fund manager, marking a significant expansion to both companies’ Polish renewable energy portfolios.

Masdar Expands European presence with Acquisition of 1GW Renewable Portfolio in Poland

Masdar and Taaleri Energia have purchased the projects from Domrel Biuro Usług Inwestycyjnych (Domrel), a leading developer in the Polish renewable energy market specializing in the development of RES power plants across Poland. They will maintain an ongoing relationship with Domrel to progress the projects through the required developmental stages.

Once operational, the eight projects, which include solar photovoltaic (PV) and onshore wind technologies, will have a combined capacity of more than 1 gigawatt (GW), enough to supply approximately 223,000 households and offset 1.8 million tonnes of carbon dioxide each year. They represent a significant expansion in Masdar’s growing European portfolio.

By developing hybrid PV solar and wind projects, Masdar is capitalizing on recent amendments to the Polish Energy Law, known as Cable Pooling, which allow for the linking of different renewable energy sources in a single grid connection.

Solar and wind power rarely operate at full capacity at the same time due to the intermittent power generation from wind and the sun. Cable Pooling helps to stabilize renewable energy generation at each connection, while optimizing the grid to ensure reliable power supply to homes and businesses across Poland. The amendment, which entered into force in October 2023, is expected to add approximately 25GW of renewable capacity in Poland.

The agreement was signed by Masdar Head, Development and Investment (Europe), Amalia Giannakikou, Taaleri Energia Investment Director, Stephen Butler and Domrel Business Development Manager, Michał Wiśniewski.

It was witnessed by the Polish Ambassador to the UAE, His Excellency Mr Jakub Slawek, the President of the Management Board of Bank Gospodarstwa Krajowego, Beata Daszyńska-Muzyczka, Masdar Director, Development & Investment (EMEA), Ahmed Al Awadi, Domrel Development Chief Executive Officer, Maciej Chmielarski and Taaleri Energia Managing Director, Kai Rintala.

Masdar Chief Executive Officer Mohamed Jameel Al Ramahi said: "This bold, progressive step expands our portfolio in Europe and supports Poland in achieving its climate action goals. We applaud Poland’s recent legislative developments in the renewable and clean energy sector, which have opened the door for additional renewable capacity by allowing hybrid solar-wind projects to connect to the grid. As a global clean energy pioneer, we are proud to be investing in new and innovative technologies and project structures in Poland and across Europe which will provide reliable, secure and sustainable energy for businesses and communities."

This landmark announcement builds on Masdar’s existing investments and commitments in Poland, including the Mlawa Wind Farm, located in Mazowieckie in the north of the country, and the Grajewo Wind Farm, located in Podlaskie, in the north-east. The projects were inaugurated in 2021 and have a combined installed operational capacity of 51.4MW.

Taaleri Energia Managing Director, Kai Rintala said: "We are delighted with the acquisition of these eight Polish hybrid renewable energy projects. Our partnership with Masdar is an extremely valuable part of our investment strategy in the CEE region. This deal brings the total number of development projects in our SolarWind III Fund portfolio to 61, representing a potential gross generation capacity of 7.6GW."

Domrel Chief Executive Officer, Maciej Chmielarski, said: "We are very pleased to establish cooperation with partners that are leaders in their home markets and are also dynamically expanding their operations beyond them. For us, a key reason for entering into this strategic collaboration was a shared vision of Poland’s future and common values that bind us as partners with Masdar and Taaleri."

Poland is seeking to increase installed wind capacity to 11GW by 2040 and solar PV to 10-16GW by the same year. Masdar’s investments in the country will support the nation in meeting the ambitious targets set out in the Energy Policy of Poland, which will have a significant impact on reducing carbon emissions in the country.

About Masdar

Abu Dhabi Future Energy Company (Masdar) is the UAE’s clean energy champion and one of the fastest growing companies in the world, advancing the development and deployment of renewable energy and green hydrogen technologies to address global sustainability challenges. Established in 2006, Masdar has developed projects in over 40 countries, helping them to achieve their clean energy objectives and advance sustainable development. Masdar is jointly owned by Abu Dhabi National Oil Company (ADNOC), Mubadala Investment Company (Mubadala), and Abu Dhabi National Energy Company (TAQA), and under this ownership the company is targeting a renewable energy portfolio capacity of at least 100 gigawatts (GW) by 2030 and an annual green hydrogen production capacity of up to 1 million tonnes by the same year.

About Taaleri Energia

Taaleri Energia is a renewable energy developer and fund manager with one of the largest dedicated renewables investment teams in Europe, managing a 9.7GW wind, solar and battery storage portfolio in Europe, the US and the Middle East.

For more information please visit: http://www.masdar.ae and connect: facebook.com/masdar.ae and twitter.com/masdar

This material is distributed by Daniel J. Edelman, Inc. on behalf of Masdar. Additional information is available at the Department of Justice, Washington, DC.

Source : Masdar Expands European presence with Acquisition of 1GW Renewable Portfolio in Poland

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SUZHOU, China, Dec. 4, 2023 /PRNewswire/ — Recently, Crystal Pharmatech’s CDMO Business Unit – Crystal Formulation Services (CFS) successfully obtained dual certification in Good Manufacturing Practices (GMP)[1] and Good Distribution Practices (GDP)[2] from SGS, an internationally recognized third-party certification agency, in line with the World Health Organization (WHO) standards. This significant milestone signifies that CFS has met the requirement of international authoritative certification standards in various aspects such as technical capabilities, quality management systems, compliance, and facility construction.

During the certification inspection, SGS dispatched experienced certification inspectors for a comprehensive one-week on-site evaluation of CFS. Through various methods such as company presentations, document reviews, personnel interviews, and dynamic inspection of production activities, SGS meticulously scrutinized CFS’s quality management system, factory facilities, equipment, and workforce expertise. Based on the comprehensive observations, the inspection team accorded complete recognition and endorsement.

WHO GMP/GDP is a comprehensive and internationally recognized set of guiding principles that serve as key standards for the global pharmaceutical industry. As a leading global third-party independent audit and certification organization, SGS issues compliance certificates based on WHO GMP/GDP guidelines, which are widely acknowledged and esteemed within the industry. This certification signifies that CFS’s systems and facilities align with internationally accepted good manufacturing and distribution practices for pharmaceuticals, providing reliable quality assurance for our services in local and international multi-center clinical trials. It will help ensure that our services consistently meet high-quality standards and fulfill customer expectations.

CFS’s Clinical Supply Center offers end-to-end one-stop clinical supply services, covering all supply services in the research and development stages, including pre-clinical, clinical phases I-III, and post-market studies. With GMP-compliant storage capabilities in temperature zones ranging from 15°C-25°C, 2°C-8°C, -20°C and deep freezing, as well as an electronic management system, we provide services such as primary and secondary packaging, storage and distribution, import and export, recycling and disposal, procurement of comparator drugs and ancillary materials. With a professional project management and operation team with over a decade of industry experience, CFS ensures professional, accurate, compliant, and efficient clinical supply services.

Additionally, as a specialized oral dosage form CDMO, Crystal Formulation Services has established a quality management system that complies with GMP standards in China, the United States, and Europe, holding the NMPA (National Medical Products Administration) drug production license and having successfully passed compliance audits from numerous of domestic and international innovative pharmaceutical companies. We adhere to core values of technical expertise and integrity, committed to providing customers with high-quality formulation development and manufacturing services.

Dr. Decheng Ma, CEO of Crystal Formulation Services, stated: "We are very grateful to SGS experts for their guidance on CFS’s quality management system and the professional and rigorous inspection, which has garnered high recognition for CFS. CFS has always been committed to serving global pharmaceutical clients with high standards of quality and efficiency. We also appreciate the efforts of our team members and the authoritative certification from SGS, which has provided a prestigious endorsement for our clinical supply business. We will continue to accelerate and look forward to the soaring success of our clinical supply operations!"

Dr. Alex M. Chen, Chairman and CEO of Crystal Pharmatech, remarked, "The successful attainment of GMP/GDP certification demonstrates the compliance of Crystal Formulation Services’ quality management system and facility construction. It further strengthens the trust relationship we have with our partners and customers. In the future, Crystal Formulation Services will continue to enhance our internal quality management system, refine our crystalline and formulation capabilities, and ensure that our research and development, production, and clinical supply services consistently adhere to high-quality standards. By starting with the end in mind, we are dedicated to continually supporting the steady and rapid development of our pharmaceutical clients."

To know more, please visit https://www.crystalpharmatech.com or contact us via [email protected]. 

[1] GMP Certificate: Crystal Formulation Services can provide primary packaging services for clinical drugs under temperature conditions of 15-25°C (such as blister packs, bottles, bubble wraps); also provides secondary packaging services for different temperature conditions of 15-25°C, 2-8°C, and -25 to -15°C (such as blister cards, cartons, and corresponding labeling operations).

[2] GDP Certificate: Crystal Formulation Services can provide storage (receiving and storing) and transportation (shipping and retrieval) services for clinical drugs under different temperature conditions of 15-25°C, 2-8°C, and -25 to -15°C.

Source : Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SEOUL, South Korea, Dec. 4, 2023 /PRNewswire/ — As the December holiday season approaches, d’Alba the acclaimed beauty brand is gearing up to offer exclusive discounts on all gift sets, ensuring a festive and value-packed celebration for customers! The perfect opportunity to indulge in the joy of giving and receiving premium skincare.

d’Alba Premium Vegan Italian White Truffle Skincare Line

d’Alba’s White Truffle First Spray Serum, maintains its #1 position in the Face Mist category during the Black Friday Cyber Monday period, marking another significant achievement. The brand witnessed a notable surge in sales, achieving the Amazon No.1 Face Mist status this November. Black Friday saw record-breaking daily sales and continued to set new monthly sales records. The d’Alba Spray Serum line, recorded an impressive 48,790 units sold, averaging 1.25 units purchased per minute.

Celebrity influencer James Charles, known for his massive following, has chosen d’Alba’s products as his favorites, further boosting the brand’s popularity. James Charles openly expressed his affection not only for the hero product, the White Truffle First Spray Serum, but also for the White Truffle Double Layer Revitalizing Serum and White Truffle Double Serum & Cream.

Looking ahead to 2024, d’Alba plans to bring the brand closer to consumers by expanding beyond e-commerce to retail shops, inspired by positive results and popularity on Amazon in the fourth quarter of 2023. The brand’s growth extends not only in the United States but also in the UK and Australia.

In the UK, the White Truffle First Spray Serum achieved the impressive feat of securing the 2nd position in Amazon’s Face Sprays & Mists category. In Australia, d’Alba clinched the 4th position in Amazon’s Face Serum category. Rankings for the highly moisturizing White Truffle Double Layer Revitalizing Serum experienced a significant rise, accompanied by increased purchases for other products beyond the hero items.

Source : Skincare Delights: d'Alba's #1 Status and Holiday Surprises Await!

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SANTA MONICA, Calif., Dec. 5, 2023 /PRNewswire/ — EarFun’s development kitchen remains hot. Delivering their first IEM and portable USB-C DAC just this past month, the awarded audio brand will be releasing the next generational leap from their current lineup, the Free Pro 3. 

EarFun Free Pro 3 – The World’s 1st Snapdragon Sound and Hi-Res Audio Hybrid ANC Earbuds

Revolutionizing True Wireless Audio and Noise Cancelation

The new true wireless earbuds are the first pair of earbuds that combine Snapdragon Sound Certification, Hi-Res audio, Qualcomm’s QCC3072 SoC, the latest v5.3 Bluetooth certification, Low-Energy Audio protocol, and aptX Adaptive technology. It will also feature EarFun’s proprietary QuietSmart™ 2.0 technology for active noise cancellation up to 43dB, and 6-mic cVc call noise-reduction. It will boast a generous battery life of up to 33 hours, an IPX5 certification, wireless charging, and multipoint connectivity. The Free Pro 3 will make use of EarFun’s customizable audio app for total user configuration.

Dual Snapdragon and Hi-Res Certification

The new Free Pro 3 revolutionizes the wireless audio experience with its inclusion of numerous advanced audio and connectivity certifications and enhancements. Qualcomm’s Snapdragon Sound Certification and Hi-Res certification make the Free Pro 3 the first to combine both certifications to achieve the highest level of wireless audio quality and connectivity. Bluetooth 5.3 is featured with the latest version, further improving device connection speed, distance connected, and the sound of compressed audio. The Qualcomm QCC 3072 SoC brings aptX Adaptive Audio to support low-latency and secure connection with connected devices. Alongside these features is improved performance efficiency, lending to its extended battery life at no expense to sound quality.

QuietSmart 2.0 and Enhanced Ergonomics

EarFun’s house-designed intelligent hybrid active noise-cancellation technology, aptly named QuietSmart 2.0, increases environmental reduction by a deeper 43dB. To achieve this impressive rating, it integrates a total of 6 microphones (3 per earbud) that use Qualcomm cVc 8.0 Echo Canceling and Noise Suppression (ECNS) tech that quells unwanted environmental noises and accurately isolates voices during calls. Three modes are offered (ANC / Ambient Sound / Normal) to help users adjust according to their environmental needs. Supporting sound isolation and sound quality, are the included five pairs of silicone tips and three pairs of ear hooks. The included tips accommodate ear canal variance (XS, S, M, L, XL) to achieve a complete seal, and the three hooks allow for improved fitting and removal.

App Customization and Multiple Devices

The EarFun Free Pro 3 will be compatible with the brand’s audio app. Button assignment, 10-band equalizer adjustment, changing device connection, and toggling between noise-canceling modes can be done using the EarFun Audio app. Thanks to the implementation of the low-latency aptX protocol, the <55ms latency Game Mode can also be accessed through the app, syncing sound and motion when console or PC gaming. And bringing games and movies to life are Dual 7mm Wool Composite Drivers that achieve total immersion. Once user are done gaming, the Multipoint Connectivity feature keeps the other device connected when they’re ready to switch over.

33hrs of Efficient Playback and Wireless Charging

Since the EarFun Free Pro 3 adopts the latest audio SoC and Bluetooth 5.3, it can deliver a more efficient 7.5 hours per charge. And thankfully, the increase in battery life is delivered at no compromise to the audio experience. With the included USB-C and Wireless Rechargeable case, users can extend the total playback to a reliable 33 hours. Protecting the tech inside the Free Pro 3 is the IPX5 Waterproof and Sweat Resistance certification.

Pricing and Availability

EarFun Free Pro 3 is available on myearfun.com and Amazon.com for $79.99 now and will be offered in three colors – Brown Black / Silver White / Navy Blue.

For more information on EarFun Free Pro 3 and the rest of the EarFun wireless audio collection, visit www.myearfun.com.

About EarFun

EarFun, an audio brand established in California in 2018, is run by an experienced group of industrial designers, acoustic engineers and music enthusiasts who shared the goal of creating next-generation wireless audio devices. The EarFun team is driven by a passion for music and a commitment to delivering solutions that use the latest technology to improve sound for wireless audio products. EarFun has become one of the most acclaimed wireless audio brands worldwide within just 3 years.

Media Contact: Helen Shaw, [email protected] 

Source : EarFun Revolutionizes Wireless Audio with Free Pro 3 – The World's First Snapdragon Sound and Hi-Res ANC Earbuds

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

NEW YORK and LONDON, Dec. 4, 2023 /PRNewswire/ — The Global Board of PricewaterhouseCoopers International Limited (PwCIL) today announced that Mohamed Kande has been selected as the next Chair of the PwC Network. His four-year term, which has been ratified by PwC’s worldwide network of member firms, will commence on 1 July 2024. 

Mr. Kande, who has worked at PwC since 2011, is a member of PwC’s Global Leadership Team and has served as Global Advisory Leader since 2019. In addition, he serves as the co-leader of US Consulting Solutions. Mohamed has previously held various multi-territory leadership roles and been responsible for helping our global stakeholders and clients solve their most complex problems.

Mohamed has over 32 years of professional services experience and brings a wealth of multi-industry and multi-disciplinary experience. He is a licensed CPA, holds an MBA from the University of Chicago and earned an MS in electrical engineering from the University of Montreal and a diplôme d’ingénieur in electrical engineering from Ecole Supérieure d’Ingénieurs en Génie Electrique in France.

Lisa Sawicki, PwC Network Governance Board Chair, said: 

"Mohamed is a purpose-led leader with broad multidisciplinary experience and will bring tremendous insights and perspective to the role of Global Chair. He is committed to implementing our global strategy, our multidisciplinary operating model and collaborating closely with our partners and people to help our clients and stakeholders build trust and drive sustained outcomes. Mohamed’s global experience, commitment to diversity and inclusion and understanding of cutting-edge technologies make him the ideal Chair to guide PwC into the future." 

Mohamed Kande, PwC Global Chair-elect, said: 

"It is a great honour to be selected as the next Global Chair of the PwC Network as we enter our 175th year in business. I look forward to working with my colleagues around the world as we continue to help our clients and stakeholders build trust, deliver quality and drive sustained outcomes. That said, the world is changing quickly and the needs of our clients, our people and the communities we live in are also changing. I am extremely confident that PwC has the right strategy, the right multidisciplinary operating model and the right values in place to help our clients through these challenges and opportunities. I look forward to building on those in the next four years."

Mr Kande will succeed Bob Moritz, who has served as Global Chair since 2016. Bob will retire at the end of his term on 30 June 2024, concluding a four decade career at PwC. 

Lisa Sawicki, PwC Network Governance Board Chair, added:

"I want to thank Bob for all he has achieved, and will continue to achieve, in his role as Global Chair. In addition to driving PwC’s strategy, Bob has been committed to our people and exemplifies PwC values every day. As Chair, he has been a champion for diversity & inclusion, stakeholder capitalism and is a leading voice of the business community around major societal issues such as climate and skills development." 

Bob Moritz, PwC Global Chair, said: 

"It has been an honor and a privilege to serve this great Network as Global Chair. Having worked alongside Mohamed for over a decade, I have the utmost confidence he will continue to live our values and purpose while successfully driving the Network forward."

About PwC
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 151 countries with over 360,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

Biography of Mohamed Kande

Mohamed Kande currently serves as Vice Chair PwC US – US Consulting Solutions Co-Leader and Global Advisory Leader. He also serves as the CEO of the US and Japan Consulting businesses. In these roles, he is responsible for helping clients identify value and design and deliver large-scale business-led change, from strategy to outcomes, specifically in the areas of Deals, Transformation, Cybersecurity, Privacy and Risk, Cloud and Digital and Tax Consulting.

As part of his role at the Global Advisory Leader, Mohamed played a key leadership role in driving the Network’s Alliance strategy as well as served as the executive sponsor of the Network’s investments in key capabilities such as Gen AI, managed services, and business model reinvention.

Prior to this role, Mohamed served as PwC’s US and Global Advisory Leader for the technology, media, telecoms ("TMT") and hospitality industry sectors. His technical knowledge spans the areas of operational strategy, technology development, mergers and acquisitions and operations management.

Before joining PwC in August 2011, Mohamed was the managing partner of PRTM Management Consultants’ Europe, Middle East and South Asia business. Prior to that leadership role, he was the managing partner of PRTM’s Global Public Sector business. Mohamed also continued to be one of the senior partners in PRTM’s telecommunications and technology practice.

Prior to joining PRTM, Mohamed worked for Motorola in Chicago and for DTI Telecom in Canada, deploying and launching telecommunications networks in the USA, Europe, the Middle East, Asia and Africa.

Mohamed holds an MBA from the University of Chicago, an MS in electrical engineering from the University of Montreal and a diplôme d’ingénieur inn electrical engineering from Ecole Supérieure d’Ingénieurs en Génie Electrique in France. Mohamed became a licensed CPA in Washington, D.C., in 2022. He is on the Board of Directors of CARE, the global humanitarian organization providing disaster relief to areas in crisis, and providing long-term solutions to poverty around the world.

Source : PwC selects Mohamed Kande as next Global Chair

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

PALO ALTO, Calif., Dec. 4, 2023 /PRNewswire/ — The intuitive investment and trading platform moomoo has recently completed a third-quarter U.S. users survey. Results show that 37.1% of surveyed moomoo users feel financial stability can be achieved with relatively moderate income levels and see investing as the top path to potential financial security.

Results show that 37.1% of surveyed moomoo users feel financial stability can be achieved with relatively moderate income levels and see investing as the top path to potential financial security.

Despite calls by many economists, a recession has yet to materialize. Employment remained strong in the third quarter while inflation came down from much higher levels reached earlier in the year. Moomoo surveyed its users at the end of the third quarter to learn how they felt about their finances, how financially resilient they were, and how they were working to meet their investing goals and achieve financial freedom. Their answers painted a mixed picture of what worries them and how they were preparing for the future.

"Foremost, our users are worried about inflation and the economy. A little more income would make them less worried, and investing is seen as the number one way to get there," said Justin Zacks, Vice President of Strategy at Moomoo Technologies Inc. "Most of our users have an emergency savings fund, with a little less than half able to pay for an unexpected expense with such funds."

Results also show that investment styles and goals have shifted recently compared with the COVID-19 pandemic era. The "you only live once (YOLO)" style of investing gained popularity during the pandemic, but that popularity has since waned as many of the so-called "meme" stocks came back down to earth, unable to support lofty valuations. 81.6% of surveyed moomoo users do not use the YOLO style of investing at all.

In terms of learning about how and what to invest, moomoo users are more likely to look online for financial information than to more traditional offline resources. News articles (34.3%) and the moomoo app (26.3%) account for more than half of the sources to which users turn for their financial information. 

To learn more about the moomoo third-quarter user survey results, please download our whitepaper here.

About the Survey: The Q3 Moomoo Users survey was conducted in October, 2023. The survey included around 400 participants that are registered users of the moomoo app. The data shown in the survey represents the opinion of those surveyed, and may change based on market and other conditions. The survey results provided herein may not represent other customers’ experience, and there is no guarantee of future performance or success and should also not be construed as investment advice. Experiences may differ than the ones represented here. Investing involves risks regardless of strategy selected.

About moomoo

Moomoo is an investment and trading platform that empowers global investors with pro-grade, easy-to-use tools, data, and insights. It provides users with the necessary information and technology to make more informed investment decisions. Investors have access to advanced charting tools, technical analytics, and in-depth data. Moomoo grows with its users, cultivating a community where investors share, learn, and grow together in one place. Moomoo provides free access to investment courses, educational materials, and interactive events that any investor, at any level, can gain from. Users can join forum discussions, trending topics, and seminars to better their investment knowledge and insights.

The moomoo app is offered by Moomoo Technologies Inc. ("MTI") a company that is based in Palo Alto, California. The app is used globally in countries including the U.S., Singapore, Australia, Japan, Malaysia and Canada. MTI is not a broker-dealer and does not provide investment advice or recommendations. In the U.S., securities products and services are offered by Moomoo Financial Inc. ("MFI"), an SEC-registered broker-dealer and member FINRA/SIPC. MTI and MFI are indirect, wholly-owned subsidiaries of Futu Holdings Limited (Nasdaq: FUTU). FUTU has won multiple awards internationally, such as Fortune’s 100 Fastest Growing Companies in 2022. Moomoo is not just your investment platform. It is your investment journey.

For more information, please visit moomoo’s official website at www.moomoo.com or feel free to email: [email protected].

Source : Investing Is The Top Way to Financial Security, Moomoo Users Reveal In The 3Q Survey

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SHANGHAI, Dec. 4, 2023 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance for CT071, an autologous CAR T-cell therapy candidate targeting G protein-coupled receptor class C group 5 member D (GPRC5D), for the treatment of patients with relapsed/refractory multiple myeloma (MM) or relapsed/refractory primary plasma cell leukemia (PCL).

GPRC5D is emerging as an important target in the landscape of MM, a common but incurable hematologic malignancy characterized by the uncontrolled proliferation of plasma cells. The notable overexpression of GPRC5D on the surface of malignant plasma cells, coupled with its limited presence on normal tissues, makes GPRC5D an ideal candidate for the treatment of MM and PCL. CT071 incorporates a fully-human single-chain variable fragment (scFV) developed by CARsgen, specifically designed to target GPRC5D.

CT071 is manufactured with CARsgen’s proprietary CARcelerateTM platform, which shortens the manufacturing time to less than 2 days and therefore yields younger, healthier, and possibly more potent CAR T cells compared to conventional manufacturing. The improved manufacturing efficiency also enhances the supply capacity, reduces the manufacturing costs, and expedites the availability of the product to the patients.

An investigator-initiated trial (IIT) is already under way in China to assess the safety and efficacy of CT071 in treating relapsed/refractory MM or PCL (NCT05838131). Preliminary clinical data from the IIT shows an acceptable safety profile with preliminary efficacy.

About CT071

CT071 is a CAR T-cell therapy candidate developed utilizing proprietary CARcelerateTM platform of CARsgen targeting GPRC5D for the treatment of relapsed/refractory MM or relapsed/refractory PCL. An IIT (NCT05838131) is ongoing in China to evaluate the safety and efficacy of CT071 for the treatment of relapsed/refractory multiple myeloma or plasma cell leukemia.

About CARcelerateTM

CARcelerateTM is a proprietary platform CARsgen developed that can shorten the manufacturing time for the CAR T cells to less than 2 days, as compared to the conventional CAR T manufacturing process. The CARcelerateTM platform produces CAR T cells that are younger, healthier, are more likely to remain in a ‘naïve’ state and less likely to be exhausted; as such, these CAR T cells from the CARcelerateTM platform are expected to exhibit more potent tumor killing activity.

About CARsgen Therapeutics Holdings Limited

CARsgen is a biopharmaceutical company with operations in China and the U.S. and is focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. CARsgen has established a comprehensive CAR T-cell research and development platform, encompassing target discovery, innovative CAR T-cell development, clinical trials, and commercial-scale production. CARsgen has internally developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. CARsgen’s vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable.

Forward-looking Statements

All statements in this press release that are not historical fact or that do not relate to present facts or current conditions are forward-looking statements. Such forward-looking statements express the Group’s current views, projections, beliefs and expectations with respect to future events as of the date of this press release. Such forward-looking statements are based on a number of assumptions and factors beyond the Group’s control. As a result, they are subject to significant risks and uncertainties, and actual events or results may differ materially from these forward-looking statements and the forward-looking events discussed in this press release might not occur. Such risks and uncertainties include, but are not limited to, those detailed under the heading "Principal Risks and Uncertainties" in our most recent annual report and interim report and other announcements and reports made available on our corporate website, https://www.carsgen.com. No representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on, any projections, targets, estimates or forecasts contained in this press release.

Contact CARsgen
For more information, please visit https://www.carsgen.com/
Public Relations: [email protected]
Investor Relations: [email protected] 

Source : CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network